Loading chat...
GA SR832
Resolution
Status
Engrossed
3/27/2018
Primary Sponsor
Jeff Mullis
Click for details
AI Summary
- Creates the Senate Study Committee on Risks Associated with Kratom, composed of 3 Senate members appointed by the President of the Senate, to study the use, risks, and potential need for state action regarding kratom
- Kratom is a plant from Southeast Asia marketed as an opioid painkiller replacement, addiction treatment, concentration booster, and workout enhancer, but the FDA declared it an opioid on February 6, 2018, citing risks of abuse, addiction, and death
- Kratom is already banned in 5 U.S. states (Alabama, Arkansas, Indiana, Tennessee, and Wisconsin) and 4 countries (Australia, Malaysia, Myanmar, and Thailand), and U.S. poison control calls related to kratom increased ten-fold from 2010 to 2015
- Committee members may receive per diem allowances under Code Section 28-1-8 for up to 5 days, funded from Senate appropriations
- The committee must file any findings, recommendations, or proposed legislation with the Secretary of the Senate and stands abolished on December 1, 2018
Legislative Description
Senate Study Committee on Risks Associated with Kratom; create
Last Action
Senate Passed/Adopted
3/27/2018
Full Bill Text
No bill text available